Kalvista Pharmaceuticals

Get a job referral to Kalvista Pharmaceuticals

Massachusetts, United States

51-200 Employees

Automotive

Healthcare

Tech

Description

KalVista Pharmaceuticals is a biopharmaceutical company specializing in the development of small molecule protease inhibitors for the treatment of diseases with significant unmet needs. The company's innovative approach aims to address conditions such as diabetic macular edema and hereditary angioedema by targeting key enzymes involved in disease pathways. With a focus on precision medicine and cutting-edge research, KalVista Pharmaceuticals is dedicated to improving patient outcomes and advancing the field of therapeutic protease inhibition.

Jobs

View all jobs at Kalvista Pharmaceuticals
Kalvista Pharmaceuticals

Kalvista Pharmaceuticals

Director of Corporate Communications
MA Full timeAutomotive Healthcare Tech
Kalvista Pharmaceuticals

Kalvista Pharmaceuticals

Global Regulatory Manager
MA Full timeAutomotive Healthcare Tech
Kalvista Pharmaceuticals
MA Full timeAutomotive Healthcare Tech
Kalvista Pharmaceuticals

Kalvista Pharmaceuticals

Manager, Compliance Operations
MA Full timeAutomotive Healthcare Tech
Kalvista Pharmaceuticals
MA Full timeAutomotive Healthcare Tech
Kalvista Pharmaceuticals

Kalvista Pharmaceuticals

Director, Commercial Finance
MA Full timeAutomotive Healthcare Tech
Kalvista Pharmaceuticals
MA Full timeAutomotive Healthcare Tech
Kalvista Pharmaceuticals
MA Full timeAutomotive Healthcare Tech
Kalvista Pharmaceuticals
MA Full timeAutomotive Healthcare Tech

About

Careers Page

www.kalvista.com

Financials

Type

public

Annual Revenue

--

Market Cap

$609.0M+

Referrals

Kalvista Pharmaceuticals accepts referrals. The typical bonus is $--. Read more about Kalvista Pharmaceuticals referral bonuses.

Subscribe to Refer Me premium to get referred to your dream role at Kalvista Pharmaceuticals!

Your career is worth investing in.

Get unlimited referrals with Premium.

Upgrade to Premium

Refer Me logo

Refer Me

Referrals

Get Referred

Subscription

© 2025 Crucible Fund LLC. All rights reserved.